Evaluation of indium-111 pentetreotide somatostatin receptor scintigraphy to detect recurrent thyroid carcinoma in patients with negative radioiodine scintigraphy.

Valli, N; Catargi, B; Ronci, N; Leccia, F; Guyot, M; Roger, P; Ducassou, D; Tabarin, A

Valli, N; Catargi, B; Ronci, N; Leccia, F; Guyot, M; Roger, P; Ducassou, D; Tabarin, A.

Affiliation

Valli N; Service de Médecine Nucléaire, Hôpital du Haut Lévèque CHU de Bordeaux, Pessac, France.

Thyroid ; 9(6): 583-9, 1999 Jun.

Article in En | MEDLINE | ID: mdl-10411121

Subject(s)

Carcinoma, Papillary/diagnostic imaging; Radiopharmaceuticals; Receptors, Somatostatin/metabolism; Somatostatin/analogs & derivatives; Thyroid Neoplasms/diagnostic imaging; Adult; Aged; Carcinoma, Papillary/metabolism; Child; Female; Humans; Indium Radioisotopes; Iodine Radioisotopes; Lymphatic Metastasis; Male; Middle Aged; Radionuclide Imaging; Thyroglobulin/metabolism; Thyroid Neoplasms/metabolism; Tomography, X-Ray Computed

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Somatostatin / Thyroid Neoplasms / Carcinoma, Papillary / Receptors, Somatostatin / Radiopharmaceuticals Type of study: Prognostic_studies Limits: Adult / Aged / Child / Female / Humans / Male / Middle aged Language: En Journal: Thyroid Journal subject: ENDOCRINOLOGIA Year: 1999 Document type: Article Affiliation country: France

Search on Google

Add to My VHL

XML

PubMed Links